Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · IEX Real-Time Price · USD
7.23
-0.02 (-0.28%)
May 17, 2024, 4:30 PM EDT - Market closed
Nanobiotix Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Nanobiotix stock has a target of 11, which predicts an increase of 52.14% from the current stock price of 7.23.
Analyst Consensus: Buy
* Price targets were last updated on Dec 8, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for Nanobiotix is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Mar '24 | Apr '24 | May '24 |
---|---|---|---|
Strong Buy | 0 | 0 | 0 |
Buy | 1 | 1 | 1 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Initiates $11 | Buy | Initiates | $11 | +52.14% | Dec 8, 2023 |
Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 6, 2021 |
Financial Forecast
Revenue This Year
57.94M
from 36.21M
Increased by 60.01%
Revenue Next Year
41.26M
from 57.94M
Decreased by -28.79%
EPS This Year
-0.80
from -1.08
EPS Next Year
-1.07
from -0.80
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 83.6M | 81.8M | 70.0M | 56.0M | 113.8M |
Avg | 57.9M | 41.3M | 36.0M | 29.1M | 110.5M |
Low | 33.3M | 2.9M | 3.8M | 3.6M | 106.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 130.8% | 41.2% | 69.7% | 55.6% | 291.5% |
Avg | 60.0% | -28.8% | -12.8% | -19.2% | 280.3% |
Low | -8.0% | -94.9% | -90.9% | -90.0% | 265.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.71 | -1.10 | 0.56 | -0.19 | 0.75 |
Avg | -0.80 | -1.07 | -0.43 | -0.65 | 0.73 |
Low | -0.88 | -1.03 | -1.35 | -1.07 | 0.70 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.